Pulmonary granulomatous diseases possess a common set of pathologic events which appear to be due, in part, to the recruitment and activation of leukocytes. Although the initiating insult may vary, as in the eitiology of sarcoidosis, tuberculosis, or beryllosis, the subsequent immune response, characterized by infiltrating mononuclear cells, is often similar. While the exact mechanism(s) by which leukocytes are elicited to the granuloma are not known, it is likely that the local production of specific chemotactic factors is critically important. This application will focus on the role of a novel chemotactic cytokine, Monocyte Chemoattractant Protein-1 (MCP), in the initiation and maintenance of granulomatous inflammation. The working hypothesis of this application is that the expression of MCP during the initiation and maintenance of pulmonary granulomatous inflammation is one of the major mechanisms for the recruitment of blood born monocytes to the developing lesion. Accumulating evidence suggests that the expression of MCP during the development of an inflammatory lesion is influenced by a cytokine network, involving proximal mediators which can induce MCP expression by resident stromal and parenchymal cells. Thus, non-immune cells may play a key role in the initiation of the local immune response by synthesizing specific chemotactic factors. The following questions will be addressed: What is the time course in the expression of MCP during the development of a pulmonary granulomatous response? What is the contribution of MCP to the initiation and maintenance of the granulomatous lesion? What are the cytokine networks which can either positively or negatively influence the expression of MCP by immune and non-immune cells? What are the molecular mechanisms which regulate the expression of MCP? Two well established models will be utilized. Highly active, T cell /macrophage mediated pulmonary granulomas will be established by embolizing Schistosoma mansoni eggs to the lungs of mice, resulting in a characteristic Delayed-Type Hypersensitivity (DTH) response. Foreign body-type lung granulomas will be induced by the embolization of sized Sephadex beads. In addition, lung granulomas will be studied in animals receiving Sephadex beads impregnated with specific cytokines to induce MCP production. The role of MCP in the initiation and maintenance of granulomatous inflammation will be studied at the whole organ, cellular, and molecular levels. Techniques used include: bioassays for monocyte chemotaxis, ELISAs for MCP quantitation, immunohistochemistry for antigen localization, and Northern blot, mRNA stability, in situ hybridization, and nuclear transcriptional analysis for assessing the expression and regulation of MCP mRNA. Studies contained in this proposal will provide novel information regarding the recruitment phase of granulomatous inflammation, will determine cellular and molecular mechanisms of MCP expression and regulation (using both animal and cell culture models), and will address a phase of granulomatous inflammation which may be amenable to therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL035276-06
Application #
3349026
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1987-07-01
Project End
1996-06-30
Budget Start
1992-07-02
Budget End
1993-06-30
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Trujillo, Glenda; O'Connor, Erica C; Kunkel, Steven L et al. (2008) A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am J Pathol 172:1209-21
Wen, Haitao; Hogaboam, Cory M; Gauldie, Jack et al. (2006) Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile. Am J Pathol 168:1940-50
Freeman, Christine M; Stolberg, Valerie R; Chiu, Bo-Chin et al. (2006) CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses. J Immunol 177:4149-58
Ness, Traci L; Ewing, Jillian L; Hogaboam, Cory M et al. (2006) CCR4 is a key modulator of innate immune responses. J Immunol 177:7531-9
Cheng, Sara S; Lukacs, Nicholas W; Kunkel, Steven L (2002) Eotaxin/CCL11 is a negative regulator of neutrophil recruitment in a murine model of endotoxemia. Exp Mol Pathol 73:1-8
Blease, Kate; Schuh, Jane M; Jakubzick, Claudia et al. (2002) Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 160:481-90
Cheng, Sara S; Lukacs, Nicholas W; Kunkel, Steven L (2002) Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells. J Immunol 168:2887-94
Cheng, S S; Lai, J J; Lukacs, N W et al. (2001) Granulocyte-macrophage colony stimulating factor up-regulates CCR1 in human neutrophils. J Immunol 166:1178-84
Blease, K; Jakubzick, C; Westwick, J et al. (2001) Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 166:5219-24
Lukacs, N W; Hogaboam, C; Chensue, S W et al. (2001) Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 120:5S-8S

Showing the most recent 10 out of 121 publications